Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Absolute Bioavailability Study of Evacetrapib in Healthy Subjects Using the Intravenous Tracer Method

NCT02271425 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02271425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Absolute Bioavailability Study of Evacetrapib in Healthy Subjects Using the Intravenous Tracer Method
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2014
Completion date
November 30, 2014
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers